Pharmaceutical Industry on Pace for Record Lobbying Spending
Pfizer, Merck, Eli Lilly and other drug giants are spending record amounts on lobbying as they fight the Trump administration on vaccine policies and more.
Pfizer, Merck, Eli Lilly and other drug giants are spending record amounts on lobbying as they fight the Trump administration on vaccine policies and more.
We run down the recipients of drugmaker donations revealed in PhRMA's latest tax filing.
House Democratic leadership groups have given more than a million dollars to the PhRMA-funded Center Forward, which has worked to undermine the Biden administration on drug pricing reforms and more.
Tax documents reveal the group Center Forward received a record $18.8 million in 2021 and spent big to back conservative Democrats who bucked their party on drug pricing reforms.
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.
Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.